Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have earned an average rating of “Mode...
Wealth Enhancement Advisory Services LLC purchased a new stake in Nektar Therapeutics (NASDAQ:NKTR -...
Nektar Therapeutics (NASDAQ:NKTR - Free Report) - Research analysts at B. Riley lowered their Q2 202...
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) had its price objective hoisted by research anal...